Browser storage is unavailable. Keep this page open and export your collection before leaving.
Biotech pharma

Hepatx
Overview
Our vision is to provide regenerative medicine treatments that free patients from chronic liver disease and help usher in an era where diseased and damaged tissues can be repaired.
Company description As recorded 2026-11-08
Founders & team
Previously Hepatx Corporation
Company history As recorded 2026-11-08
Founder profile As recorded 2026-09-15
4team members reported
Source-reported As recorded 2026-09-15
Founded 2015 · Source
News & product activity
Cohort membership
Summer 2018Summer 2018
Original evidence ↗Sources & observations
Profile depthverified profile
Website observationwebsite reachable
Last website check2026-11-11
Location · source statedBend, OR, USA; Palo Alto, CA, USA
Pricing evidenceNo pricing page confirmed
Maturity: Not assessed · 3 of 6 areas documented
Source-based assessment · automated evidence rules
The retained text does not establish product availability or customer use.
Maturity is an evidence-based assessment, not a success rating. It may understate the current stage where evidence is limited. Coverage records documented areas, not a complete or independently audited company history.
- Product overviewSource description Checked 2026-11-08
- Product visualsNot documented
- Founders & originsTeam information
- Business model & pricingNot documented
- Funding & ownershipNot documented
- Dated milestonesDated source activity: 2018 Q3 (quarter only)
independent websitesource corroborationreachable websitedescriptive evidenceclassified market and modelsourced peoplesourced founding year





